Clinical TrialChronic PainRecruiting

Ketamine Enhances Analgesia and Mood in Chronic Pain Patients

This observational cohort study (n=500) aims to assess the impact of ketamine injections on analgesia and mood in chronic pain patients with associated mood disorders.

Target Enrollment
500 participants
Study Type
Phase NA observational
Design
Non-randomized

Detailed Description

Prospective observational cohort of adult chronic pain clinic patients receiving routine ketamine injections; pre- and post-injection data are collected to evaluate changes in pain and mood.

Outcomes include numeric pain rating scale (≥2-point change considered significant), Likert sleep scale (≥2-point change), GAD-7 for anxiety (≥4-point change) and PHQ-9 for depression (≥5-point change); analyses performed with SPSS using t-tests, ANOVA, chi-square and regression.

Participants

Ages
20 – 99
Sexes
Male & Female

Inclusion Criteria

  • Inclusion Criteria:
  • adult chronic pain patients
  • associated mood disorder
  • good treatment compliance
  • associated chronic insomnia
  • regular ketamine pain therapy injection
  • consent for clinical record quality assurance review

Exclusion Criteria

  • Exclusion Criteria:
  • severe cognitive disorder
  • inability to provide consent
  • major neuropsychiatric disorder
  • cannabis use
  • stimulant use
  • substance abuse
  • poor treatment compliance
  • lack of ketamine pain therapy injection

Study Details

  • Status
    Recruiting
  • Phase
    Phase NA
  • Type
    observational
  • Design
    Non-randomized
  • Target Enrollment500 participants
  • Timeline
    Start: 2018-02-02
    End: 2023-12-31
  • Topic
    Chronic Pain

Locations

Salem Anaesthesia Pain Clinic — Surrey, British Columbia, Canada

Your Library